1.261 S E C T I O N I I Pharmacology “Take me, I am the drug; take me, I am hallucinogenic.” ––Salvador Dali “I was under medication when I made the decision not…
1. 11 Challenges in Designing Pharmacogenomics Clinical Trials Joseph Levy, PhD Teva Pharmaceutical Industries MedicReS 2013 Istanbul 2. 2 The present One Size fits all 3.…
ENDOMETRIAL CARCINOMA TRIGGER: 55 years old, nulliparous lady come to clinic for bleeding per vaginal for 2 weeks. She was menopause for 3 years duration. She had diabetes…
Slide 1 JENNY MORRISON AM REPORT 6/10/2009 Oncology Board Review Slide 2 Overview Cancer statistics Malignancies Breast Cancer Ovarian Cancer Prostate Cancer…
Slide 1 Screening and Detection in Cancer Survivors Jose W. Avitia, MD Oncology/Hematology Slide 2 Slide 3 Slide 4 Breast Cancer Slide 5 Summary of 2012 ASCO guideline recommendations…
San Antonio Breast Cancer Symposium 2010 San Antonio Breast Cancer Symposium 2012 Helen K. Chew, MD, FACP Professor of Medicine Objectives Adjuvant tamoxifen duration (S1-2)…
San Antonio Breast Cancer Symposium 2010 San Antonio Breast Cancer Symposium 2012 Helen K. Chew, MD, FACP Professor of Medicine Objectives Adjuvant tamoxifen duration (S1-2)…
A Harborside Press Publication Editor-in-Chief, James O. Armitage, MD ASCOPost.com VOLUME 1, ISSUE 4 SEPTEMBER 2010 continued on page 2 Elderly women with estrogen receptor…